Glutamate measurement in Parkinson's disease using MRS at 3 T field strength. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue NMR in Biomedicine Année : 2007

Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.

Résumé

Loss of nigral dopamine neurons in Parkinson's disease induces abnormal activation of glutamate systems in the basal ganglia. The purpose of this study was to assess these changes in the lentiform nucleus using MRS with optimized glutamate sensitivity (TE-averaged method). Ten patients with Parkinson's disease and 10 healthy controls were examined. Compared with healthy controls, no significant differences in glutamate were measured in patients, but a trend to lower total creatine was observed.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00381742 , version 1 (17-08-2009)

Identifiants

Citer

Nils Kickler, Paul Krack, Valérie Fraix, Jean-François Lebas, Laurent Lamalle, et al.. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.. NMR in Biomedicine, 2007, 20 (8), pp.757-62. ⟨10.1002/nbm.1141⟩. ⟨inserm-00381742⟩
95 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More